BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 22155003)

  • 1. The molecular basis for inhibition of sulindac and its metabolites towards human aldose reductase.
    Zheng X; Zhang L; Zhai J; Chen Y; Luo H; Hu X
    FEBS Lett; 2012 Jan; 586(1):55-9. PubMed ID: 22155003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural analysis of sulindac as an inhibitor of aldose reductase and AKR1B10.
    Cousido-Siah A; Ruiz FX; Crespo I; Porté S; Mitschler A; Parés X; Podjarny A; Farrés J
    Chem Biol Interact; 2015 Jun; 234():290-6. PubMed ID: 25532697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An old NSAID revisited: crystal structure of aldose reductase in complex with sulindac at 1.0 Å supports a novel mechanism for its anticancer and antiproliferative effects.
    Steuber H
    ChemMedChem; 2011 Dec; 6(12):2155-7. PubMed ID: 21997888
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhibition of human aldose and aldehyde reductases by non-steroidal anti-inflammatory drugs.
    Ratliff DM; Martinez FJ; Vander Jagt TJ; Schimandle CM; Robinson B; Hunsaker LA; Vander Jagt DL
    Adv Exp Med Biol; 1999; 463():493-9. PubMed ID: 10352724
    [No Abstract]   [Full Text] [Related]  

  • 5. Structure-activity relationships and molecular modelling of new 5-arylidene-4-thiazolidinone derivatives as aldose reductase inhibitors and potential anti-inflammatory agents.
    Maccari R; Vitale RM; Ottanà R; Rocchiccioli M; Marrazzo A; Cardile V; Graziano AC; Amodeo P; Mura U; Del Corso A
    Eur J Med Chem; 2014 Jun; 81():1-14. PubMed ID: 24819954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of extracellular signal-regulated kinase 1/2 phosphorylation and induction of apoptosis by sulindac metabolites.
    Rice PL; Goldberg RJ; Ray EC; Driggers LJ; Ahnen DJ
    Cancer Res; 2001 Feb; 61(4):1541-7. PubMed ID: 11245463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apoptosis primarily accounts for the growth-inhibitory properties of sulindac metabolites and involves a mechanism that is independent of cyclooxygenase inhibition, cell cycle arrest, and p53 induction.
    Piazza GA; Rahm AK; Finn TS; Fryer BH; Li H; Stoumen AL; Pamukcu R; Ahnen DJ
    Cancer Res; 1997 Jun; 57(12):2452-9. PubMed ID: 9192825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antineoplastic drugs sulindac sulfide and sulfone inhibit cell growth by inducing apoptosis.
    Piazza GA; Rahm AL; Krutzsch M; Sperl G; Paranka NS; Gross PH; Brendel K; Burt RW; Alberts DS; Pamukcu R
    Cancer Res; 1995 Jul; 55(14):3110-6. PubMed ID: 7606732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The inhibition of bovine lens aldose reductase by Clinoril, its absorption into the human red cell and its effect on human red cell aldose reductase activity.
    Crabbe MJ; Freeman G; Halder AB; Bron AJ
    Ophthalmic Res; 1985; 17(2):85-9. PubMed ID: 3920599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetics and molecular docking studies of an anti-diabetic complication inhibitor fucosterol from edible brown algae Eisenia bicyclis and Ecklonia stolonifera.
    Jung HA; Islam MN; Lee CM; Oh SH; Lee S; Jung JH; Choi JS
    Chem Biol Interact; 2013 Oct; 206(1):55-62. PubMed ID: 23994501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial uncoupling by the sulindac metabolite, sulindac sulfide.
    Leite S; Martins NM; Dorta DJ; Curti C; Uyemura SA; dos Santos AC
    Basic Clin Pharmacol Toxicol; 2006 Oct; 99(4):294-9. PubMed ID: 17040214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of K-ras activation on the survival responses of Caco-2 cells to the chemopreventive agents sulindac and difluoromethylornithine.
    Lawson KR; Ignatenko NA; Piazza GA; Cui H; Gerner EW
    Cancer Epidemiol Biomarkers Prev; 2000 Nov; 9(11):1155-62. PubMed ID: 11097222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of acidic non-steroidal anti-inflammatory drugs on human cytochrome P450 4A11 activity: Roles of carboxylic acid and a sulfur atom in potent inhibition by sulindac sulfide.
    Itoh H; Yamashita N; Kamijo S; Masuda K; Kato H; Yamaori S
    Chem Biol Interact; 2023 Sep; 382():110644. PubMed ID: 37499995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. X-ray structure of the V301L aldo-keto reductase 1B10 complexed with NADP(+) and the potent aldose reductase inhibitor fidarestat: implications for inhibitor binding and selectivity.
    Ruiz FX; Cousido-Siah A; Mitschler A; Farrés J; Parés X; Podjarny A
    Chem Biol Interact; 2013 Feb; 202(1-3):178-85. PubMed ID: 23295227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetics and molecular docking studies of kaempferol and its prenylated derivatives as aldose reductase inhibitors.
    Jung HA; Moon HE; Oh SH; Kim BW; Sohn HS; Choi JS
    Chem Biol Interact; 2012 May; 197(2-3):110-8. PubMed ID: 22543015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a new class of potent aldose reductase inhibitors: Design, microwave-assisted synthesis, in vitro and in silico evaluation of 2-pyrazolines.
    Sever B; Altıntop MD; Demir Y; Yılmaz N; Akalın Çiftçi G; Beydemir Ş; Özdemir A
    Chem Biol Interact; 2021 Aug; 345():109576. PubMed ID: 34252406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of aldose reductase inhibition and docking studies of some secondary metabolites, isolated from Origanum vulgare L. ssp. hirtum.
    Koukoulitsa C; Zika C; Geromichalos GD; Demopoulos VJ; Skaltsa H
    Bioorg Med Chem; 2006 Mar; 14(5):1653-9. PubMed ID: 16249088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apo2L/TRAIL differentially modulates the apoptotic effects of sulindac and a COX-2 selective non-steroidal anti-inflammatory agent in Bax-deficient cells.
    He Q; Luo X; Huang Y; Sheikh MS
    Oncogene; 2002 Sep; 21(39):6032-40. PubMed ID: 12203115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Effect of Halogen-to-Hydrogen Bond Substitution on Human Aldose Reductase Inhibition.
    Fanfrlík J; Ruiz FX; Kadlčíková A; Řezáč J; Cousido-Siah A; Mitschler A; Haldar S; Lepšík M; Kolář MH; Majer P; Podjarny AD; Hobza P
    ACS Chem Biol; 2015 Jul; 10(7):1637-42. PubMed ID: 25919404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis, in vitro and in silico investigation of aldose reductase inhibitory effects of new thiazole-based compounds.
    Sever B; Altıntop MD; Demir Y; Akalın Çiftçi G; Beydemir Ş; Özdemir A
    Bioorg Chem; 2020 Sep; 102():104110. PubMed ID: 32739480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.